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ABSTRACT
Purpose Data on myopia progression during its entire 
course are scarce. The aim of this study is to investigate 
myopia progression in Europeans as a function of age 
and degree of myopia from first prescription to final 
refractive error.
Methods The Drentse Refractive Error and Myopia 
Study assessed data from a branch of opticians in the 
Netherlands from 1985 onwards in a retrospective study. 
First pair of glasses prescribed was defined as a spherical 
equivalent of refraction (SER) ≤−0.5 D to ≥−3.0 D. 
Subjects with prescriptions at an interval of at least 
1 year were included in the analysis.
Results A total of 2555 persons (57.3% female) met 
the inclusion criteria. Those with first prescription before 
the age of 10 years showed the strongest progression 
(−0.50 D; IQR: −0.75 to −0.19) and a significantly 
(p<0.001) more negative median final SER (−4.48 D; 
IQR: −5.37 to −3.42). All children who developed SER 
≤−3 D at 10 years were highly myopic (SER ≤−6D) as 
adults, children who had SER between −1.5 D and −3 D 
at 10 years had 46.0% risk of high myopia, and children 
with SER between −0.5 D and −1.5 D had 32.6% risk 
of high myopia. Myopia progression diminished with 
age; all refractive categories stabilised after age 15 years 
except for SER ≤−5 D who progressed up to −0.25 D 
annually until age 21 years.
Conclusion Our trajectories of the natural course of 
myopia progression may serve as a guide for myopia 
management in European children. SER at 10 years is an 
important prognostic indicator and will help determine 
treatment intensity.
INTRODUCTION
The current worldwide increase in myopia preva-
lence is leading to a growing public health burden, 
as the more high levels of myopia (≤−6 D) can lead 
to blinding complications such as myopic macular 
degeneration, retinal detachment, glaucoma and 
choroidal neovascularisation.1–3 Risk factors for 
high myopia at adult age are a young age of onset 
and a fast progression rate during childhood.4–6
Myopia onset occurs typically during childhood, 
teenage years or adolescence.4 7 The average age of 
myopia onset varies among gender, ethnicities and 
presence of parental myopia.8 Other established 
risk factors for myopia are more intense education, 
less time outdoors and increased near work that 
appear to coincide with an earlier onset.9–12 The 
strongest progression of eye growth is observed 
in early childhood, while stabilisation may not 
occur until late adolescence.13 14 Around 90% of all 
myopic individuals appear to be stable at the age of 
21 years, and nearly all by the age of 24 years.8
Most existing data on myopia progression have 
been provided by controlled myopia intervention 
studies, which have a short follow- up period, limited 
numbers or are based on imputed data.8 15 16 Longi-
tudinal studies in Europeans with 10- year follow- up 
are available, but time interval between the onset of 
myopia and final refractive error might be longer. 
This limits robust insights into the association 
between age of onset and final refractive error.17 
The aim of this study is to describe myopia growth 
trajectories and the association between the first 
myopic prescription and final refractive error in a 
cohort of European children.
METHODS
Study population
The Drentse Refractive Error And Myopia (DREAM) 
Study population comprised of subjects who bought 
their glasses from 1 of the 14 dispensing opticians 
from a chain of stores belonging to 1 family. The 
stores were located in the north of the Netherlands 
including the provinces Overijssel, Friesland, Gron-
ingen and Drenthe. The area has 1.7 million inhabi-
tants and is classified as a non- urban area with 37% 
of the people living in an urban environment.18 
Ethnicity was an unknown variable in this study; 
however, according to the open source Statistics 
Netherlands’ database, personsin the region with a 
non- western background was approximately 3% in 
1980 to 5% in 2015.18 Records of eyeglass orders 
were stored digitally since 1985, and all data gath-
ered since that time up to 2015 entered the current 
analysis. Eligibility criteria were at least two orders 
of myopic eyeglasses with an interval of 1 year or 
more until the age of 25 years. Final degree of 
myopia was obtained from a visit between 22 and 
25 years of age. Subjects were born between 1962 
and 1997; follow- up time ranged from 1 to 22 
years with a mean of 5.82 years (SD 4.1). Data were 
completely anonymised by the dispensing opticians 
and in full compliance with the European General 
Data Protection Regulation.
Refractive error and myopia
Assessment of refractive error was done by multiple 
eye care providers, however, compatible with Dutch 
health guidelines, refractive error was determined 
by an orthoptist or an ophthalmologist under cyclo-
plegia up to 12 years of age, and was performed by 
a qualified optician at older ages. Spherical equiva-
lent of refraction (SER) was calculated as an average 
sphere +½ cylinder for both eyes. Myopia was 
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defined as SER of −0.50 D or worse of the prescribed glasses 
and high myopia was defined as ≤−6.00 D. Contact lens data 
were used if subjects moved from glasses to contact lenses. The 
back vertex formula in reversed order was used to calculate the 
contact lens prescription into those of glasses Fg=Fc/(1+xFc) in 
which Fg is the glasses prescription in diopters, Fc contact lenses 
prescription and x the vertex distance in metres (0.0125).
Statistical analysis
First purchases of myopic eye glasses with refractive error up 
to −3 D were eligible for the primary analysis; first purchases 
with more severe myopia were only eligible for myopia progres-
sion analyses. Data were presented as medians and IQRs, the 
percentiles or numbers and percentages. SER and progression 
rates showed a non- normal distribution, and a non- parametric 
test was used. Differences in progression between spherical 
equivalent groups (−1 D to −2 D; −2 D to −3 D; −3 D to 
−4 D; −4 D to −5 D; −5 D to −6 D; −6 D to −7 D) at 
baseline were compared using Kruskal- Wallis test; differences 
between female and male progression using Mann- Whitney U 
test. The association of SER progression at different age intervals 
in the same children was determined using Spearman’s correla-
tion. The mean myopic SER and the percentiles were calculated 
per age group (<10 years n=253; 10–12 y/a n=562; 13–15 y/a 
n=729; 16–18 y/a n=882; 19–21 y/a n=1270). The progres-
sion in SER from one age group to the subsequent age group 
was calculated, as were annual progression rates by the ratio 
between SER progression and time between visits. For the distri-
bution of myopia progression per age category, we calculated 
the 5th, 10th, 25th, 50th, 75th, 90th and 95th percentile values 
of myopic SER as annual progression. The cumulative risk of 
incident high myopia (ie, an SER of −6.0 D or more) was esti-
mated by Kaplan- Meier product limit analysis stratified for first 
myopic prescription and SER categories. P values below 0.05 
were considered statistically significant for all statistical tests. All 
statistical tests were performed by using IBM SPSS Statistics for 
Windows, V.25.0.
RESULTS
A total of 2555 (57.3% female) subjects were eligible for the 
progression analyses; 946 (37.0%, 59.2% female) had a first 
myopic prescription (SER between −0.5 D and −3 D) and 
refraction at adult age (22+ years) (online supplemental table 1). 
Median refractive error at adult age for the complete cohort was 
−2.50 D (IQR; −4.01 to −1.5), the proportion of high myopia 
was 8.9% (n=113).
Figure 1 shows the progression of SER per age of onset cate-
gory (n=946). Earlier first myopic prescription was significantly 
associated with a higher degree of myopia (p<0.001) at adult 
age. The median annual progression of SER decreased with age; 
this was −0.50 D (IQR: −0.75 to −0.19) in ages up to 10 years; 
−0.38 D (IQR: −0.63 to −0.19) at ages 10–12 years; −0.19 
D (IQR: −0.34 to −0.06) ages 13–15 years; −0.09 D (IQR: 
−0.21 to 0) at ages 16–18 years; and −0.08 D (IQR: −0.21 to 
0) at ages 19–21 years. Female subjects showed a significantly 
stronger progression in only one age category: 19–21 years, 
−0.09 D females versus −0.06 D males (p=0.01; figure 2). 
Figure 3 shows the annual progression of SER per age category. 
The annual progression is much greater for those with early onset 
myopia ≤12 years compared with over 12 years. Until 12 years, 
median progression was more than −0.25 D/year; beyond 16 
years, only the 90th and 95th percentile progressed more than 
−0.25 D/year. Plots for the median annual progression per age 
category stratified for adult SER are shown in figure 4. Subjects 
with high myopia at adult age had progressed with −0.71 D/
year (IQR: −0.91 to −0.56) up to age 10 (figure 4fF); milder 
myopes at adult age had progressed at a lower rate in the first 
decade (figure 4A–E).
We estimated the risk of high myopia as a function of refrac-
tive error in age categories (figure 5, time to event curve, online 
supplemental table 2). All subjects with SER −3 D or worse in 
childhood up to 10 years developed high myopia. Those with 
SER −4.5 D to −6 D at age 10 years developed high myopia at 
11.2 y/a (95% CI, 10.0 to 12.5), those with −3 D to −4.5 D at 
10 years did so at 16.0 years (95% CI, 12.9 to 19.0). Remark-
ably, those with SER −0.5 D to −1.5 D and −1.5 D to −3.0 
D up to 10 years still had, respectively, 32.6% and 46.0% risk 
to develop high myopia by age 25 years; those with SER −0.5 
D to −1.5 D and −1.5 D to −3.0 D at 10–12 years had only 
3.0% and 18.2% risk. Those who had SER −0.5 D to −1.5 
D at later ages had virtually no risk of high myopia. However, 
those who had moderate myopia, SER −1.5 D to −3.0 D and 
−3 D to −4.5 D, at age 15 years still had 11.8% and 23.2% risk 
of developing high myopia. Correlation between progression at 




































Age groups of wearing first glasses
Figure 1 Median spherical equivalent of refraction in diopters in 
children from first prescription of myopia and adult myopia obtained at 
the age of 22–25.





















< 10 y/a              10-12 y/a              13-15 y/a              16-18 y/a              19-21 y/a
Figure 2 Boxplots of median annual progression of spherical 
equivalent of refraction in diopters for boys (blue) and girls (red) per age 
group. Lower and upper box boundaries 25th and 75th percentiles and 
lower and upper error lines 2.5th and 97.5th percentiles. Tested with 
non- parametric Mann- Whitney U test.
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years and 13–15 years R=0.33; between 16–18 years and 19–21 
years R=0.23 (all p≤0.01). Correlation between progression at 
13–15 years and 16–18 years was R=0.13 (p=0.02).
DISCUSSION
This study describes myopia progression in 2555 European chil-
dren who received glasses during childhood or teenage years 
and who were followed until age 25 years. The SER at adult 
age ranged from −0.5 D to −12.75 D, with a median of −3.00 
D. Of those who developed high myopia, 60% had a first pair 
of glasses before age 10 years. Children who developed −3 D 
or worse in the first decade all developed high myopia. High 
myopes at adult age had been faster progressors during the 
entire youth, those with lower refractive errors virtually ceased 
progression after age 15 years.
Many clinics all over the world are offering myopia control 
using various strategies. Good myopia management requires 
insight into the natural course of myopia progression, as the goal 
is to slow down the rate. Clinical trials have attempted to provide 
these data by control groups, but the relatively short duration of 
these studies have hampered long- term predictions. Our study 
is unique as it studies myopia progression until age 25 years in 
a very large Dutch cohort. The cohort consisted of individuals 
who had bought their glasses at a branch of dispensing opticians 
from a family business, with a loyal clientele and a collective 
registration system. Progression rates in this cohort were in line 
with other European studies, suggesting that our results are 
generalisable to the European population at large.8 17 19–21
Potential limitations of our study should also be mentioned. 
The design was retrospective and included persons who devel-
oped myopia in the time period 1980–2000. Children growing 
up then may not be representative of children of today, who 
are likely to perform even more near work and spend less time 
outdoors. Participants were from an area with a relative low 
population density; only 37% lived in an urban environment.18 
Nevertheless, this did not lead to lower progression rates than 
other studies in European children. Important risk factors such 
as outdoor exposure and near activities were not assessed in the 
study. This was a limitation because of the retrospective study 
design and could explain why children with mild myopia at age 
10 still developed high myopia. Unfortunately, this cannot be 
explained by this study due to the lack of data on these and 
other risk factors for myopia progression. Another drawback is 
the classification of first prescription of ≤−0.5 D to −3.0 D 
instead of a variable onset of myopia which may have led to 
misclassification of persons to an older group.
Persons with a first myopic prescription before the age of 
10 years developed a median SER of −4.48 D (IQR: −5.37 
to −3.42) at adult age. In the American Correction of Myopia 
Evaluation Trial (COMET) carried out during the turn of the 
century, white children with a myopia onset at 6–11 years 
showed mean SER of −5.04 D (SD 0.14) at stabilisation.8 Our 
median annual progression in children younger than 10 years 
(SER −0.45 D; IQR: −0.69 to −0.20) and from 10 to 12 
(−0.38 D; IQR: −0.19 to −0.54) corresponded well with the 
mean 3- year progression rate in the 8–12 year control group of 
the MiSight Lenses study (−1.24 D, SD 0.61 in 3 years), with the 
7- year- old participants of an Australian cohort (−0.41 D) but 
was slightly more than the 3- year progression rate in the 6–7 to 
9–10 year old white European children in the Northern Ireland 
Childhood Errors of Refraction (NICER) Study (−1.14 D, 95% 
CI, −3.13 to −0.63).19 20 22 Our rate in children aged 13–15 
years (−0.19 D, IQR: −0.33 to −0.08) was slightly more than 
the mean 3- year progression rate in children from the NICER 
Study (−0.33 D, 95% CI, −1.63 to 0.63) but less than the 
annual rate of 13- year- old Australians (−0.31 D), though 47.3% 
of these children was of non- western background.20 22 Our rate 
appeared somewhat lower than the progression in 6–15- year- old 
children of the 2- year low dose atropine study from Los Angeles 
(−1.2 D; SD 0.7 in 2 years), but this retrospective study included 








































Figure 3 Progression curves in percentiles representing annual 
progression rate of spherical equivalent in diopters as a function of age 
for European myopic subjects. Percentiles were calculated per age group 
and are connected by dashed lines.
Figure 4 Boxplots of median annual progression in diopter spherical equivalent per adult degree of myopia category obtained at the age of 22–25. 
Lower and upper box boundaries 25th and 75th percentiles and lower and upper error lines 2.5th and 97.5th percentiles. SER, spherical equivalent of 
refraction.
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reported higher rates (−0.8 D/year).23 Progression of myopia 
decelerated with age in our study to −0.05 (IQR: −0.13 to 0.0) 
in those aged 19–21 years, which was slightly less compared 
with the progression found in the mean annual progression by 
the NICER Study (−0.09, 95% CI, −0.51 to +0.19) in children 
12–20 years.24 Higher degrees of adult myopia showed faster 
progression, especially before the age of 13 (figure 4). These age 
patterns confirm observations from others who also found the 
steepest progression patterns in the youngest age group.8 17 20 25–27
High myopia is clinically the most significant outcome of 
myopia. Our time- to- event curves provide insight for devel-
opment of this refractive error category as a function of age 
(figure 5). All persons with SER −3 D at 10 years developed 
high myopia by adult age. We think this degree of refractive 
error developed in the first decade can serve as an indicator for 
professionals to maximise myopia control and lifestyle advice 
to reduce final refractive error. Unfortunately, lower refractive 
errors at age 10 did not exclude development of high myopia; 
hence, all children with a first myopic prescription below 10 
years of age should be followed with care.
Similar to the children in the COMET Trial, gender was not 
associated with the final degree of myopia. Asian studies did 
find predilection for females, girls had both higher mean SER 
and stronger progression. Although we observed a slight gender 
difference in progression rate in one age category, this differ-
ence was minimum and did not exceed −0.03 D/year.28 Lifestyle 
seems to be a likely explanation to the findings in Asian girls.
In conclusion, our results provide myopic refractive error 
trajectories during the entire youth for Europeans and present 
the risk of high myopia as a function of age and refractive error 
in childhood. With its practical simplicity, the DREAM study can 
be used to evaluate myopia progression in white children and 
may serve as a guide for treatment outcomes in myopia control 
programmes.
Twitter Jan Roelof Polling @jan_roelof
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